| Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome T Ishida, A Utsunomiya, S Iida, H Inagaki, Y Takatsuka, S Kusumoto, ... Clinical Cancer Research 9 (10), 3625-3634, 2003 | 417 | 2003 |
| Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma S Kusumoto, Y Tanaka, M Mizokami, R Ueda International journal of hematology 90, 13-23, 2009 | 238 | 2009 |
| Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress M Ri, S Iida, T Nakashima, H Miyazaki, F Mori, A Ito, A Inagaki, ... Leukemia 24 (8), 1506-1512, 2010 | 212 | 2010 |
| Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγ null mouse model A Ito, T Ishida, H Yano, A Inagaki, S Suzuki, F Sato, H Takino, F Mori, M Ri, ... Cancer immunology, immunotherapy 58, 1195-1206, 2009 | 190 | 2009 |
| Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing M Ri, E Tashiro, D Oikawa, S Shinjo, M Tokuda, Y Yokouchi, T Narita, ... Blood cancer journal 2 (7), e79-e79, 2012 | 185 | 2012 |
| Hepatic toxicity and prognosis in hepatitis C virus–infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese … D Ennishi, Y Maeda, N Niitsu, M Kojima, K Izutsu, J Takizawa, ... Blood, The Journal of the American Society of Hematology 116 (24), 5119-5125, 2010 | 167 | 2010 |
| Monitoring of hepatitis B virus (HBV) DNA and risk of HBV reactivation in B-cell lymphoma: a prospective observational study S Kusumoto, Y Tanaka, R Suzuki, T Watanabe, M Nakata, H Takasaki, ... Clinical Infectious Diseases 61 (5), 719-729, 2015 | 166 | 2015 |
| Stevens–Johnson S yndrome associated with mogamulizumab treatment of adult T‐cell leukemia/lymphoma T Ishida, A Ito, F Sato, S Kusumoto, S Iida, H Inagaki, A Morita, S Akinaga, ... Cancer science 104 (5), 647-650, 2013 | 143 | 2013 |
| Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy S Kusumoto, Y Tanaka, R Ueda, M Mizokami Journal of gastroenterology 46, 9-16, 2011 | 127 | 2011 |
| Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy S Kusumoto, L Arcaini, X Hong, J Jin, WS Kim, YL Kwong, MG Peters, ... Blood, The Journal of the American Society of Hematology 133 (2), 137-146, 2019 | 119 | 2019 |
| The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma T Ishida, T Ishii, A Inagaki, H Yano, S Kusumoto, M Ri, H Komatsu, S Iida, ... Leukemia 20 (12), 2162-2168, 2006 | 119 | 2006 |
| Regulatory T‐cell function of adult T‐cell leukemia/lymphoma cells H Yano, T Ishida, A Inagaki, T Ishii, S Kusumoto, H Komatsu, S Iida, ... International journal of cancer 120 (9), 2052-2057, 2007 | 98 | 2007 |
| CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment Y Sakamoto, T Ishida, A Masaki, T Murase, K Yonekura, Y Tashiro, ... Blood, The Journal of the American Society of Hematology 132 (7), 758-761, 2018 | 86 | 2018 |
| Defucosylated anti–CC chemokine receptor 4 monoclonal antibody combined with immunomodulatory cytokines: a novel immunotherapy for aggressive/refractory mycosis fungoides and … H Yano, T Ishida, A Inagaki, T Ishii, J Ding, S Kusumoto, H Komatsu, ... Clinical cancer research 13 (21), 6494-6500, 2007 | 82 | 2007 |
| Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation T Inoue, S Kusumoto, E Iio, S Ogawa, T Suzuki, S Yagi, A Kaneko, ... Journal of hepatology 75 (2), 302-310, 2021 | 81 | 2021 |
| Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype N Matsuno, M Osato, N Yamashita, M Yanagida, T Nanri, T Fukushima, ... Leukemia 17 (12), 2492-2499, 2003 | 81 | 2003 |
| Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular … K Shimada, M Yamaguchi, Y Atsuta, K Matsue, K Sato, S Kusumoto, ... The Lancet Oncology 21 (4), 593-602, 2020 | 80 | 2020 |
| Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2Rγnull mice in vivo A Ito, T Ishida, A Utsunomiya, F Sato, F Mori, H Yano, A Inagaki, S Suzuki, ... The Journal of Immunology 183 (7), 4782-4791, 2009 | 78 | 2009 |
| The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to … J Ding, H Komatsu, S Iida, H Yano, S Kusumoto, A Inagaki, F Mori, M Ri, ... Blood, The Journal of the American Society of Hematology 114 (15), 3325-3328, 2009 | 76 | 2009 |
| Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma T Narita, T Ishida, A Ito, A Masaki, S Kinoshita, S Suzuki, H Takino, ... Blood, The Journal of the American Society of Hematology 130 (9), 1114-1124, 2017 | 71 | 2017 |
